Skip to main content
. 2020 Oct;8(20):1308. doi: 10.21037/atm-20-6373

Figure 3.

Figure 3

ZSCAN31 was down-regulated after TAZ knockdown and highly expressed in HCC tissues after surgical resection. (A) Determination of the expression level of ZSCAN31 in HCC cell line (HepG2) by reverse transcription-polymerase chain reaction and western blot. Data are expressed as mean ± standard deviation (SD). *, P<0.05. (B) Determination of the protein levels of TAZ in 83 clinical HCC samples. (C) Immunostaining of HCC samples in a tissue microarray with a monoclonal anti-ZSCAN31 antibody (up 40×, down 100×). TAZ, transcriptional coactivator with PDZ binding motif; ZSCAN31, SCAN domain-containing protein 31; HCC, hepatocellular carcinoma.